Clinical Trial Update: Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin in combination with paclitaxel for metastatic or recurrent head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma Head and Neck

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• metformin (metformin)

Snippet

Sponsor: Lucas Vieira dos Santos | Conditions: Head and Neck Neoplasms, Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED